Prelude Fertility offers the Prelude Method, a bundled fertility service that includes egg freezing and preservation, embryo creation when ready, genetic screening for inherited diseases and chromosomal abnormalities, and single‑embryo transfer. The company markets two product plans with different down payments—the Prelude Saver Plan ($3,000 down) and the Prelude Conceive Plan ($10,000 down—and a financing option that starts at $199 per month. After the four‑year financing term, Prelude says monthly storage of vitrified embryos and/or eggs drops to $99 per month. Prelude also works with partners to facilitate egg donations (paying donors between $7,000 and $8,000 per cycle, limited to six cycles) and partners with My Egg Bank (MEB) North America to supply donor egg lots (one lot of six eggs priced at $11,000). As of the article, the company has secured $200 million in private equity and, as a private company, does not disclose other financial details. Martin Varsavsky is founder, chairman and CEO.

Total raised

$200M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2017